Michael Thurn

Director/Board Member at AROVELLA THERAPEUTICS LIMITED

Net worth: 119 276 $ as of 30/06/2026

Health Technology

Consumer Services

Health Services

Profile

Michael Thurn is the founder of Marp Therapeutics Pty Ltd. Dr. Thurn is currently a Non-Executive Director at Arovella Therapeutics Ltd. since 2026, a Director at Inmagene Biopharmaceuticals, and a Director at Impel Neuropharma.
Formerly, Dr. Thurn was Chief Executive Officer at Mimetica Pty Ltd. from 2006 to 2014, Chief Executive Officer at Neurizon Therapeutics Ltd. from 2023 to 2024, Chief Operating Officer & Executive Director at Botanix Pharmaceuticals Ltd. from 2019 to 2020, Managing Director at Spinifex Pharmaceuticals Pty Ltd., Director at Erasca, Inc., Non-Executive Director at Neurizon Therapeutics Ltd. in 2026, Team Leader at Kazia Therapeutics Ltd., Chief Operating Officer at YM BioSciences Australia Pty Ltd., Head-Drug Development at Xenome Ltd., and Senior Toxicologist at Therapeutic Goods Administration.
Dr. Thurn earned a doctorate from the University of Technology Sydney in 1994.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NEURIZON THERAPEUTICS LIMITED 0.38%	07/11/2024	2,869,276 ( 0.38% )	119 276 $	30/06/2026

Michael Thurn active positions

Companies	Position	Start
AROVELLA THERAPEUTICS LIMITED	Director/Board Member	28/04/2026

All active positions of Michael Thurn

Former positions of Michael Thurn

Companies	Position	End
NEURIZON THERAPEUTICS LIMITED	Chief Executive Officer	16/03/2026
NEURIZON THERAPEUTICS LIMITED	Chief Executive Officer	23/04/2024
BOTANIX PHARMACEUTICALS LIMITED	Chief Operating Officer	26/02/2020
ERASCA, INC.	Director/Board Member	-
Marp Therapeutics Pty Ltd. Marp Therapeutics Pty Ltd. Medical/Nursing ServicesHealth Services Provides therapy services	Founder	-

See the detail of Michael Thurn's experience

Training of Michael Thurn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Thurn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Kazia Therapeutics Ltd. Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development	Health Technology
Botanix Pharmaceuticals Ltd. Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products	Health Technology
Arovella Therapeutics Ltd. Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables	Health Technology
YM BioSciences Australia Pty Ltd. YM BioSciences Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops cancer treatment pharmaceuticals	Health Technology
Xenome Ltd. Xenome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide pharmaceuticals	Health Technology
Neurizon Therapeutics Ltd. Neurizon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceutical products	Health Technology
University of Technology Sydney University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Mimetica Pty Ltd. Mimetica Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of acne	Health Technology
Spinifex Pharmaceuticals Pty Ltd. Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain	Health Technology
Therapeutic Goods Administration
Erasca, Inc. Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers	Health Technology
Marp Therapeutics Pty Ltd. Marp Therapeutics Pty Ltd. Medical/Nursing ServicesHealth Services Provides therapy services	Health Services